NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NASDAQ:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, announced today that the Company will present at the LD Micro Conference on Tuesday, April 29th at 5:00 PM PDT. Senior Vice President Corporate Development, William Prather RPh, MD, will represent the Company. The conference will be held at the Omni Los Angeles Hotel in Los Angeles, California.
